Improving access to HIV treatment in Africa using geographic analysis
Using geospatial science to maximize the opportunity to access ART in Africa
['FUNDING_R01'] · UNIVERSITY OF CALIFORNIA LOS ANGELES · NIH-10892659
This study is looking at how where you live in Sub-Saharan Africa affects your access to HIV treatment, and it aims to find ways to make it easier for people to get the care they need.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA LOS ANGELES (nih funded) |
| Locations | 1 site (LOS ANGELES, UNITED STATES) |
| Trial ID | NIH-10892659 on ClinicalTrials.gov |
What this research studies
This research aims to identify and reduce geographic disparities in access to antiretroviral therapy (ART) for people living with HIV in Sub-Saharan Africa. By developing a spatial interaction model, the team will analyze data from Malawi to understand how location affects access to HIV care. The study will quantify the relationship between access opportunities and actual ART utilization, and propose strategies to improve access for underserved populations. This approach combines data analysis with geographic science to create actionable insights.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV in Sub-Saharan Africa, particularly those facing challenges in accessing ART.
Not a fit: Patients living outside Sub-Saharan Africa or those not affected by HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve access to HIV treatment for individuals in underserved regions of Africa.
How similar studies have performed: Previous research has shown success in using geographic analysis to address health disparities, indicating that this approach has potential for impactful outcomes.
Where this research is happening
LOS ANGELES, UNITED STATES
- UNIVERSITY OF CALIFORNIA LOS ANGELES — LOS ANGELES, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BLOWER, SALLY MARGARET — UNIVERSITY OF CALIFORNIA LOS ANGELES
- Study coordinator: BLOWER, SALLY MARGARET
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome, Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome Virus